CN102481320A - 在糖尿病前期和2型糖尿病中血清淀粉样蛋白的表型比例 - Google Patents

在糖尿病前期和2型糖尿病中血清淀粉样蛋白的表型比例 Download PDF

Info

Publication number
CN102481320A
CN102481320A CN2010800370719A CN201080037071A CN102481320A CN 102481320 A CN102481320 A CN 102481320A CN 2010800370719 A CN2010800370719 A CN 2010800370719A CN 201080037071 A CN201080037071 A CN 201080037071A CN 102481320 A CN102481320 A CN 102481320A
Authority
CN
China
Prior art keywords
saa
variant
phenotype
phenotype ratio
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800370719A
Other languages
English (en)
Chinese (zh)
Inventor
U·A·基尔南
D·内代利科维
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intrinsic Bioprobes Inc
Original Assignee
Intrinsic Bioprobes Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intrinsic Bioprobes Inc filed Critical Intrinsic Bioprobes Inc
Publication of CN102481320A publication Critical patent/CN102481320A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
CN2010800370719A 2009-07-07 2010-07-02 在糖尿病前期和2型糖尿病中血清淀粉样蛋白的表型比例 Pending CN102481320A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22349809P 2009-07-07 2009-07-07
US61/223,498 2009-07-07
PCT/US2010/040997 WO2011005717A1 (en) 2009-07-07 2010-07-02 Phenotypic ratio of serum amyloid in pre- and type 2 diabetes

Publications (1)

Publication Number Publication Date
CN102481320A true CN102481320A (zh) 2012-05-30

Family

ID=43427764

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800370719A Pending CN102481320A (zh) 2009-07-07 2010-07-02 在糖尿病前期和2型糖尿病中血清淀粉样蛋白的表型比例

Country Status (5)

Country Link
US (1) US20110008799A1 (enExample)
EP (1) EP2451465B1 (enExample)
JP (1) JP5748751B2 (enExample)
CN (1) CN102481320A (enExample)
WO (1) WO2011005717A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113080114A (zh) * 2021-04-12 2021-07-09 浙江大学 一种提高鱼类子代成活率的方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160112810A (ko) * 2015-03-20 2016-09-28 삼성전자주식회사 이미지 처리 방법 및 그 전자 장치

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070087448A1 (en) * 2004-02-16 2007-04-19 Nelsestuen Gary L Biological profiles and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020164818A1 (en) * 1995-05-23 2002-11-07 Gruber Karl F. Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids
JP2005503537A (ja) * 2001-01-17 2005-02-03 エー． タブス，ケモンズ 生体分子分析用ハイ・スループット統合システム
AUPR589801A0 (en) * 2001-06-22 2001-07-19 Autogen Research Pty Ltd Modulation of physiological processes and agents useful for same
US8119358B2 (en) * 2005-10-11 2012-02-21 Tethys Bioscience, Inc. Diabetes-related biomarkers and methods of use thereof
JP2008228646A (ja) * 2007-03-20 2008-10-02 Hokkaido Univ ２型糖尿病診断剤
CA2692970A1 (en) * 2007-07-03 2009-01-08 Northeastern University Biomarkers for diabetes, obesity, and/or hypertension

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070087448A1 (en) * 2004-02-16 2007-04-19 Nelsestuen Gary L Biological profiles and methods of use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113080114A (zh) * 2021-04-12 2021-07-09 浙江大学 一种提高鱼类子代成活率的方法

Also Published As

Publication number Publication date
EP2451465A4 (en) 2013-01-23
WO2011005717A1 (en) 2011-01-13
JP5748751B2 (ja) 2015-07-15
EP2451465A1 (en) 2012-05-16
JP2012533065A (ja) 2012-12-20
EP2451465B1 (en) 2017-08-23
US20110008799A1 (en) 2011-01-13

Similar Documents

Publication Publication Date Title
EP2984176B1 (en) Srm assay to indicate cancer therapy
Kiernan et al. Comparative phenotypic analyses of human plasma and urinary retinol binding protein using mass spectrometric immunoassay
JP2011515680A (ja) 糖尿病のためのバイオマーカーおよびアッセイ
WO2021232211A1 (zh) 诊断肾病的标志物以及诊断方法
JP5876826B2 (ja) 糖尿病前症及び２型糖尿病におけるアポリポタンパク質ｃｉｉｉ
WO2024109767A1 (zh) 基于粪便代谢物的阿尔兹海默症标志物及其应用
CN109991342A (zh) 一种诊断或预防糖尿病视网膜病变的生物标志物、检测试剂及用途
US20240393353A1 (en) Biomarker for cancer diagnosis and use thereof
JP5748751B2 (ja) 糖尿病前症及び２型糖尿病における血清アミロイドの表現型比率
WO2024109768A1 (zh) 基于血液代谢物的阿尔茨海默症标志物及其应用
CN112599237B (zh) 一种生物标志物及其在脑梗死诊断中的应用
CN118275706A (zh) 用于诊断肺癌分型的代谢标志物
CN112305089B (zh) 一种慢性肾病诊断生物标记物及其应用
KR102475926B1 (ko) 전신 홍반성 루푸스 진단용 바이오마커 조성물 및 이를 이용한 전신 홍반성 루푸스 진단에 필요한 정보를 제공하는 방법
CN113655141A (zh) 一种早期预警重症急性胰腺炎的血清极性小分子预测模型与应用
WO2021162030A1 (ja) 薬剤性間質性肺炎の代謝物診断バイオマーカー
CN115469026B (zh) 用于检测环孢素a肾毒性相关标志物的检测试剂、试剂盒及其用途
CN111413447A (zh) 鹅去氧胆酸或/和牛磺酸鹅去氧胆酸在胆管癌诊断方面的应用
CN118091146A (zh) 基于血液代谢物的神经退行性疾病标志物及其应用
WO2024108604A1 (zh) 基于血液代谢物的神经退行性疾病标志物及其应用
CN115166100A (zh) 检测ffa和/或mag的试剂在制备预测ipah发病风险的产品中的应用
WO2023079706A1 (ja) 糖尿病性腎症の判定方法
CN114829941A (zh) Lama2、plxdc2及mll4作为糖尿病前期和糖尿病的新型生物标记
CN117310179A (zh) 检测脂肪因子Ism1水平的物质在制备评估受检者肾功能的试剂中的应用
CN118311266A (zh) 一种急性胰腺炎后糖尿病鉴别诊断的标志物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120530